🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing properties. Viewers are encouraged to contact these profiles privately for supplier links, while also receiving discount codes.

Active Trade on Social Networks

Separately, a robust trade exists on Telegram, where communities with numerous of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Vendors market the substance there before directing buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Express Worries

However, physicians and pharmacists have warned that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could result in users administering substances of unknown origin.

Several professionals said the popularity for retatrutide could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate medicines, advertising, and consumer regulations, risking fines, legal action or imprisonment.

Platform Reaction and Content Elimination

Based on TikTok, the service has removed violative content and banned related hashtags and query recommendations. The organization stated it was committed to maintaining the service safe and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Investigations also found communities with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with thousands of members, populated with images of slimming results, glowing reviews and detailed instructions for preparing or injecting at home.

After moments of entering one community, a vendor shared WhatsApp details, where the majority of purchases take place. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, medical conditions or past usage.

Product Information and Pricing

Within these communities, messages show black plastic packages with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20mg. When asked how long a pen should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service stated it regularly monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting substances they can’t verify. Even if the research behind retatrutide is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.

Her staff has already seen patients harmed by personal administration from unverified sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company experimental substance not yet approved … may subject users to potentially significant medical dangers”.